SGK
GILD icon

Steigerwald Gordon & Koch’s Gilead Sciences GILD Stock Holding History

Steigerwald Gordon & Koch’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Buy
1,475
+1
+0.1% +$132 0.02% 157
2026
Q1 		$205K Sell
1,474
-108
-7% -$15.1K 0.02% 133
2025
Q4 		$194K Buy
1,582
+109
+7% +$13.2K 0.02% 148
2025
Q3 		$163K Buy
+1,473
New +$167K 0.02% 158

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steigerwald Gordon & Koch's GILD Position: Q2 2026 in Review

Steigerwald Gordon & Koch increased its Gilead Sciences (GILD) stake by 0.07% in Q2 2026, buying an estimated $132 and bringing the position to 1,475 shares worth $186K. The position accounts for 0.02% of the portfolio, ranked #157.

Steigerwald Gordon & Koch first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $205K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Steigerwald Gordon & Koch held 1,475 shares of Gilead Sciences worth $186K as of Q2 2026.
  • Steigerwald Gordon & Koch bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.02% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #157 holding.
  • Steigerwald Gordon & Koch first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Gilead Sciences position peaked at $205K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.